population at high risk of developing type 2 diabetes (T2D) included 3234 participants with impaired glucose tolerance, elevated fasting plasma glucose and BMI of ≥24 kg/m 2 , and metformin reduced the incidence of T2D by 31% compared with placebo after an
Search Results
Mojca Jensterle, Nika Aleksandra Kravos, Simona Ferjan, Katja Goricar, Vita Dolzan, and Andrej Janez
Christine Rode Andreasen, Andreas Andersen, Filip Krag Knop, and Tina Vilsbøll
enhancer sodium N-(8-(2-hydroxybenzoyl) amino) caprylate (SNAC), which protects semaglutide from degradation in the stomach and facilitates the absorption of semaglutide across the gastric mucosa ( 14 ). Effects of GLP-1RAs in type 2 diabetes
Giovanni Fanni, Petros Katsogiannos, Bipasha Nandi Jui, Magnus Sundbom, Susanne Hetty, Maria J Pereira, and Jan W Eriksson
Introduction Besides inducing significant and durable weight loss, Roux-en-Y gastric bypass (RYGB) improves glycemic control in insulin-resistant patients and can prevent or reverse type 2 diabetes mellitus (T2DM) ( 1 , 2 , 3 ). This
Amalie Carlsson, Kaspar Sørensen, Anna-Maria Andersson, Hanne Frederiksen, and Anders Juul
variety of plastic products and barrier coatings for the inner surfaces of food and beverage cans ( 2 ). Humans are primarily exposed to BPA through ingestion ( 3 ). Urinary BPA excretion has been positively associated with higher prevalence of diabetes
Lin Ji, Huan-Tong Wu, Xiao-Yan Qin, and Rongfeng Lan
a result, the inactivation of CPE causes Cpe fat /Cpe fat mice (BKS strain, primarily in males) to exhibit a slowly developing obesity at 8–12 weeks of age with mild diabetes, thus this mutation is originally named fat. These mice are hyperglycemic
Janaína Felix Braga, Daniela Ravizzoni Dartora, Natalia Alenina, Michael Bader, and Robson Augusto Souza Santos
the pathophysiology of diabetes and metabolic syndrome ( 2 ). In the past few years, our understanding of the role of the heptapeptide angiotensin(1–7) has been extended to include other organs and systems well beyond the heart, vessels and the
Paraskevi Kazakou, Stavroula A Paschou, Theodora Psaltopoulou, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia N Kassi, Meletios-Athanasios Dimopoulos, and Asimina Mitrakou
and diabetes mellitus (DM), is under investigation. However, data on new early and late onset manifestations are limited ( 8 , 9 , 10 , 11 ). The aim of this article is to review the early and late endocrine complications of COVID-19 and
Yiqiong Ma, Zhaowei Chen, Yu Tao, Jili Zhu, Hongxia Yang, Wei Liang, and Guohua Ding
Introduction As a severe type of diabetic microangiopathy, diabetic nephropathy (DN) is considered the most common cause of end-stage renal disease (ESRD) worldwide ( 1 ). In China, there are 113.9 million people with diabetes, and the
Sarantis Livadas, Christina Bothou, Justyna Kuliczkowska-Płaksej, Ralitsa Robeva, Andromahi Vryonidou, Jelica Bjekic Macut, Ioannis Androulakis, Milica Opalic, Zadalla Mouslech, Andrej Milewicz, Alessandra Gambineri, Dimitrios Panidis, and Djuro Macut
, accompanied by oligomenorrhea, dominate the clinical picture followed by metabolic disorders including dysglycemia and dyslipidemia later in life ( 1 ). Moreover, progression of normoglycemia to either intermediate hyperglycemia or diabetes mellitus (T2DM) has
Michaela Keuper
substantiate the strong association between decreased mitochondrial content and oxygen consumption of WAT/adipocytes, which is in particular evident during metabolic complications such as insulin resistance, type 2 diabetes (T2DM) and cardiovascular diseases
